跳到正文
原文
Nature 健康护理主题·· 7 天前AI 评分36

医院临床数据仓库用于肿瘤真实世界证据生成的适用性评估:一项基于PICOTS框架的可行性研究

Fitness-for-purpose of hospital clinical data warehouses for oncology real-world evidence generation: a PICOTS-informed feasibility assessment

AI 导读

该研究以韩国两家三级医院的CDW数据为基础,针对胃癌上市后研究评估159个预设变量的可获得性与完整性。其中127个(79.9%)可直接获取,2个(1.3%)可从结构化数据客观推导,21个(13.2%)可通过复合临床信息确认,9个(5.7%)不可用。

正文

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

We assessed the fitness for purpose of routinely collected data from hospital clinical data warehouses (CDWs) for a predefined oncology real-world evidence (RWE) study. Using a gastric cancer post-listing study as the empirical use case, we evaluated CDW data from two tertiary hospitals in South Korea. We examined 159 prespecified variables for availability, completeness, data format, and capture frequency, linked the variable-level findings to Population, Intervention, Comparator, Outcomes, Timing, and Setting (PICOTS) components and key covariates, and assessed system-level CDW implementation. Of 159 variables, 127 (79.9%) were directly captured, 2 (1.3%) were objectively derivable from structured data, 21 (13.2%) were ascertainable from composite clinical information, and 9 (5.7%) were unavailable. Population and Comparator eligibility, Timing, Setting, and key covariates were feasible; Intervention was feasible with caveats, whereas Outcomes had limited feasibility, particularly for clinically interpretive endpoints requiring composite clinical ascertainment. System-level implementation was high across assessed domains, whereas studyspecific variable-level limitations remained in completeness and ascertainment. Broad availability of relevant clinical information did not consistently translate into direct analytic readiness, particularly for clinically interpretive variables, indicating the need for studyspecific assessment and, where necessary, targeted clinical ascertainment, external data linkage, or validation to support the intended analysis.

Funding

This study was supported by the Health Insurance Review & Assessment Service (No. R25TA00248222-00) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number​: RS-2025-02213746).

Author information

Author notes

  1. Eurie Choi, Joohyun Kim, and Jung Ae Kim contributed equally as first-authors to this manuscript.

Authors and Affiliations

  1. Department of Pharmacy, Yonsei University, Seoul, Republic of Korea

    Eurie Choi & Euna Han

  2. Department of Information Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Joohyun Kim & Kyu-pyo Kim

  3. Department of Innovative Pharmaceutical Sciences and Engineering, Inje University, Gimhae, Republic of Korea

    Jung-Ae Kim

  4. Division of Digital Health, Yonsei University Health System, Seoul, Republic of Korea

    Seong-Gyeong Yu, Hyeon-Suk Seong, Young Ah Kim & Kyung Won Kim

  5. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Min-Hee Ryu, Kyu-pyo Kim & Jaewon Hyung

  6. Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea

    Kyung Won Kim

Authors

  1. Eurie Choi
  2. Joohyun Kim
  3. Jung-Ae Kim
  4. Seong-Gyeong Yu
  5. Hyeon-Suk Seong
  6. Young Ah Kim
  7. Min-Hee Ryu
  8. Kyu-pyo Kim
  9. Jaewon Hyung
  10. Kyung Won Kim
  11. Euna Han

Corresponding authors

Correspondence to Jaewon Hyung, Kyung Won Kim or Euna Han.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, E., Kim, J., Kim, JA. et al. Fitness-for-purpose of hospital clinical data warehouses for oncology real-world evidence generation: a PICOTS-informed feasibility assessment. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78523-0

Download citation

  • Received: 31 August 2026

  • Accepted: 27 October 2026

  • Published: 13 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78523-0

Keywords

来源:Nature 健康护理主题 · nature.com